ArticleFrontiers in immunology2021

Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.